HeartSciences Inc. (HSCS): Cost of Revenue

Annual figures by period end, from SEC filings.

$1.8K

Year ended 2026-04-30

$1.8K

Trailing 12 months to 2026-07-31

-14.2%

3-year compound annual growth

2022-04-30 Cost of Revenue (USD) 2026-04-30

Period ended	Cost of Revenue	Change YoY	Source filing
2026-04-30	$1.8K	-6.0%	2026-07-23, From 2025-05-01
2025-04-30	$1.9K	-69.1%	2026-07-23, From 2024-05-01
2024-04-30	$6.1K	+117.5%	2025-07-24, From 2023-05-01
2023-04-30	$2.8K	-64.6%	2024-07-29, From 2022-05-01
2022-04-30	$7.9K	n/a	2023-07-19, From 2021-05-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Finance Services), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Cost of Revenue	Change YoY
HeartSciences Inc. (HSCS)	2026-04-30	$1.8K	-6.0%
NetBrands Corp. (NBND)	2025-12-31	$8.8K	n/a
T-REX Acquisition Corp. (TRXA)	2025-06-30	$118.6K	+291.9%
Sentage Holdings Inc. (SNTG)	2025-12-31	$6.1K	-24.8%
Axe Compute Inc. (AGPU)	2025-12-31	$72.6K	-7.2%
SkyAI, Inc. (SKYA)	2025-12-31	$617.4K	n/a
TAO Synergies Inc. (TAOX)	2025-12-31	$38.3K	n/a
NFT Ltd (MI)	2025-12-31	$192.0K	0.0%
Hyperion Defi, Inc. (HYPD)	2025-12-31	$303.3K	-92.3%

Compare HSCS, NBND, TRXA, SNTG side by side · Screen every company in Finance Services ↗